speb/financial-data huggingface dataset:
Financial ratios for CGO.TO — quarterly report dated 2025-05-31
Total revenue: 549657246.3768116
Operating income: 133522463.76811595
Net income: 53595652.17391305
Capital expenditures: 89880434.7826087
Operating cash flow: 290851449.2753623
Depreciation & amortization: 133019565.21739131
Net tangible assets: -3741597826.086957
Owner earnings: 96734782.60869567
Return on net tangible assets (%): -2.585386968483007
Capex to operating income (%): 67.31484144772904
Buffett classification: The Good
Stock price: 44.70289855072464
P/E ratio: 1.6406460587869447
Shares outstanding: 7868080
Book value: 2576776086.956522
P/B ratio: 0.13649846558628057
Market cap (USD): 351725982.0289855
Debt to equity: 1.3886020926610068
Current ratio: 0.5169409486931268
Quick ratio: 0.5169409486931268
Effective tax rate (%): 21.78464922484719
Interest coverage ratio: 2.666275973838051
COGS to revenue (%): 0
SG&A to revenue (%): 17.153773036424543
Free cash flow (dilution-adjusted): 194850000.00000003
Buyback yield (%): 0
Retained earnings: 535668115.942029
Receivables turnover: 5.227759552296411
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.0255501994814242
FCF margin (%): 35.449364360134844
Revenue growth (%): 5.079268126206768
Rule of 40 score: 40.528632486341614
Financial ratios for CGO.TO — annual report dated 2025-08-31
Total revenue: 2195694160.5839415
Operating income: 535011678.8321167
Net income: 244645985.40145984
Capital expenditures: 420399270.0729927
Operating cash flow: 822516788.3211678
Depreciation & amortization: 525499999.99999994
Net tangible assets: -3750451094.8905106
Owner earnings: 349746715.32846713
Return on net tangible assets (%): -9.325457297788802
Capex to operating income (%): 78.57758750064806
Buffett classification: The Gruesome
Stock price: 42.007299270072984
P/E ratio: 1.3510002655408528
Shares outstanding: 7868080
Book value: 2622832116.7883205
P/B ratio: 0.126015229539585
Market cap (USD): 330516791.24087584
Debt to equity: 1.311834591236976
Current ratio: 0.4879337678351242
Quick ratio: 0.4879337678351242
Effective tax rate (%): 20.710416124529818
Interest coverage ratio: 2.646449693459753
COGS to revenue (%): 0
SG&A to revenue (%): 17.385918890356407
Free cash flow (dilution-adjusted): 370897080.2919708
Buyback yield (%): 0
Retained earnings: 547407299.2700729
Receivables turnover: 19.480500725313437
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.960610851543579
FCF margin (%): 16.892019250683404
Revenue growth (%): -3.5718418668821994
Rule of 40 score: 13.320177383801205
Financial ratios for CGO.TO — quarterly report dated 2025-08-31
Total revenue: 533844525.54744524
Operating income: 132951094.89051093
Net income: 55618248.17518248
Capital expenditures: 115778102.18978101
Operating cash flow: 194699270.07299268
Depreciation & amortization: 127694160.5839416
Net tangible assets: -3750451094.8905106
Owner earnings: 67534306.56934306
Return on net tangible assets (%): -1.8006982323099625
Capex to operating income (%): 87.08322581707779
Buffett classification: The Gruesome
Stock price: 42.007299270072984
P/E ratio: 2.03501032933282
Shares outstanding: 7868080
Book value: 2622832116.7883205
P/B ratio: 0.126015229539585
Market cap (USD): 330516791.24087584
Debt to equity: 1.311834591236976
Current ratio: 0.4879337678351242
Quick ratio: 0.4879337678351242
Effective tax rate (%): 18.48059826042302
Interest coverage ratio: 2.5933735797477
COGS to revenue (%): 0
SG&A to revenue (%): 16.957697024886272
Free cash flow (dilution-adjusted): 75361313.86861312
Buyback yield (%): 0
Retained earnings: 547407299.2700729
Receivables turnover: 4.736342088902704
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.9782221035255412
FCF margin (%): 14.116715684464843
Revenue growth (%): -2.876832959739813
Rule of 40 score: 11.23988272472503
Financial ratios for CGO.TO — quarterly report dated 2025-11-30
Total revenue: 525457857.1428572
Operating income: 134552857.14285716
Net income: 68668571.42857143
Capital expenditures: 110423571.42857143
Operating cash flow: 124737142.85714287
Depreciation & amortization: 123860714.2857143
Net tangible assets: -3694766428.571429
Owner earnings: 82105714.2857143
Return on net tangible assets (%): -2.222216637316915
Capex to operating income (%): 82.06705808657244
Buffett classification: The Gruesome
Stock price: 44.51428571428572
P/E ratio: 1.5156487351933303
Shares outstanding: 7868080
Book value: 2626135000
P/B ratio: 0.1333678432917033
Market cap (USD): 350241961.1428572
Debt to equity: 1.3054042755390936
Current ratio: 0.435331305557388
Quick ratio: 0.435331305557388
Effective tax rate (%): 21.850816153996227
Interest coverage ratio: 2.8823196388952645
COGS to revenue (%): 0
SG&A to revenue (%): 17.16462241772821
Free cash flow (dilution-adjusted): 8974285.714285715
Buyback yield (%): 0
Retained earnings: 550381428.5714287
Receivables turnover: 4.171624778841355
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.049731566708331
FCF margin (%): 1.7078982819065276
Revenue growth (%): -1.5709945505178138
Rule of 40 score: 0.1369037313887138
Financial ratios for CGO.TO — quarterly report dated 2026-02-28
Total revenue: 520463503.649635
Operating income: 124463503.64963503
Net income: 58280291.97080292
Capital expenditures: 89561313.86861314
Operating cash flow: 123163503.64963503
Depreciation & amortization: 121565693.43065692
Net tangible assets: -3697803649.635036
Owner earnings: 90284671.5328467
Return on net tangible assets (%): -2.4415755969562523
Capex to operating income (%): 71.95789226754245
Buffett classification: The Good
Stock price: 52.88321167883211
P/E ratio: 1.7618752996520233
Shares outstanding: 7868080
Book value: 2673856204.3795614
P/B ratio: 0.15561395540435738
Market cap (USD): 416089340.14598536
Debt to equity: 1.287939204784473
Current ratio: 0.4999576453130888
Quick ratio: 0.4999576453130888
Effective tax rate (%): 21.33983547608492
Interest coverage ratio: 2.6153008481725184
COGS to revenue (%): 0
SG&A to revenue (%): 18.083684531614857
Free cash flow (dilution-adjusted): 27204379.562043793
Buyback yield (%): 0
Retained earnings: 570970802.919708
Receivables turnover: 3.4754730408165253
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.8762201923171087
FCF margin (%): 5.226952393641265
Revenue growth (%): -0.9504765083119413
Rule of 40 score: 4.276475885329324
Financial ratios for CMB.AX — annual report dated 2021-06-30
Total revenue: 5981821.052631578
Gross profit: 5981821.052631578
Capital expenditures: 5852.631578947368
Buffett classification: The Gruesome
Stock price: 5.56390977443609
Shares outstanding: 29431918
Market cap (USD): 163756536.2406015
COGS to revenue (%): 0
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CMB.AX — annual report dated 2022-06-30
Operating income: -3206976.551724138
Net income: -2972227.5862068967
Capital expenditures: 5838.620689655173
Depreciation & amortization: 17213.793103448275
Net tangible assets: 741235.1724137932
Owner earnings: -2960852.413793104
Return on net tangible assets (%): -399.44845090813004
Buffett classification: The Gruesome
Stock price: 4.206896551724138
Shares outstanding: 29431918
Book value: 741235.1724137932
P/B ratio: 167.0414990449306
Market cap (USD): 123817034.34482759
Debt to equity: 0.9381991475551991
Current ratio: 0.5332938276287096
Quick ratio: 0.5332938276287096
Interest coverage ratio: -64.00181678044484
Free cash flow (dilution-adjusted): -2482577.931034483
Buyback yield (%): 0
Retained earnings: -26862972.413793106
Capitalized R&D asset: 1272287.5862068967
ROCI (R&D-adjusted, %): -117.00982027242233
Rule of 40 score: 0
Financial ratios for CMB.AX — annual report dated 2023-06-30
Operating income: -1535350.3311258277
Net income: -2236346.357615894
Capital expenditures: 18526.490066225164
Depreciation & amortization: 3496.026490066225
Net tangible assets: -1201958.940397351
Owner earnings: -2251376.821192053
Buffett classification: The Gruesome
Stock price: 0.46357615894039733
Shares outstanding: 29431918
Book value: -1291829.1390728478
Market cap (USD): 13643935.49668874
Debt to equity: -0.9981303783023404
Current ratio: 0.5599940652176657
Quick ratio: 0.5599940652176657
Interest coverage ratio: -7.988845700580974
Free cash flow (dilution-adjusted): -436858.940397351
Buyback yield (%): 0.14925001781108135
Retained earnings: -27998017.218543045
Capitalized R&D asset: 1165952.5503082897
Rule of 40 score: 0
Financial ratios for CMB.AX — annual report dated 2024-06-30
Total revenue: 479.3333333333333
Gross profit: 479.3333333333333
Operating income: -1222930.6666666667
Net income: -1503843.3333333333
Capital expenditures: 0
Depreciation & amortization: 472
Net tangible assets: 217911.33333333334
Owner earnings: -1503371.3333333333
Return on net tangible assets (%): -689.9004793998782
Buffett classification: The Gruesome
Stock price: 0.3333333333333333
Shares outstanding: 29431918
Book value: 1850887.3333333333
P/B ratio: 5.300505955521874
Market cap (USD): 9810639.333333332
Debt to equity: 0.16868305688334712
Current ratio: 1.3306753772772826
Quick ratio: 1.3306753772772826
Interest coverage ratio: -6.764021991231531
COGS to revenue (%): 0
R&D to revenue (%): 29305.702364394994
SG&A to revenue (%): 162093.32406119612
Free cash flow (dilution-adjusted): -103909.33333333333
Buyback yield (%): 0
Retained earnings: -28497891.333333332
Receivables turnover: 0.002590272248781419
Capitalized R&D asset: 770385.2147065541
ROCI (R&D-adjusted, %): -56.515872865769545
FCF margin (%): -21677.8859527121
Rule of 40 score: -21677.8859527121
Financial ratios for CPNG — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 29.38
Shares outstanding: 1637261211
Market cap (USD): 48102734379.18
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CPNG — annual report dated 2022-12-31
Total revenue: 20583000000
Gross profit: 4710000000
Operating income: -112000000
Net income: -92000000
Capital expenditures: 811000000
Operating cash flow: 565000000
Depreciation & amortization: 231000000
Net tangible assets: 2414000000
Owner earnings: -672000000
Return on net tangible assets (%): -27.83761391880696
Buffett classification: The Gruesome
Stock price: 14.71
Shares outstanding: 1637261211
Book value: 2414000000
P/B ratio: 9.97684855584507
Market cap (USD): 24084112413.81
Debt to equity: 0.9950289975144988
Current ratio: 1.1514912107446178
Quick ratio: 0.8242148923563105
Interest coverage ratio: -4.148148148148148
COGS to revenue (%): 77.11703833260458
SG&A to revenue (%): 23.427100034008646
Free cash flow (dilution-adjusted): -521000000
Buyback yield (%): 0
Retained earnings: -5743000000
Inventory turnover: 9.579360289680144
Receivables turnover: 111.86413043478261
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.5168539325842696
FCF margin (%): -2.5312150804061604
Rule of 40 score: -2.5312150804061604
Financial ratios for CPNG — annual report dated 2023-12-31
Total revenue: 24383000000
Gross profit: 6190000000
Operating income: 473000000
Net income: 1360000000
Capital expenditures: 877000000
Operating cash flow: 2652000000
Depreciation & amortization: 275000000
Net tangible assets: 4052000000
Owner earnings: 758000000
Return on net tangible assets (%): 18.70681145113524
Capex to operating income (%): 185.4122621564482
Buffett classification: The Gruesome
Stock price: 16.19
P/E ratio: 19.490631622125
Shares outstanding: 1637261211
Book value: 4089000000
P/B ratio: 6.48257740427733
Market cap (USD): 26507259006.090004
Debt to equity: 0.6815847395451211
Current ratio: 1.1363570914326855
Quick ratio: 0.8964722822174226
Effective tax rate (%): -132.87671232876713
Interest coverage ratio: 9.854166666666666
COGS to revenue (%): 74.61346019767872
SG&A to revenue (%): 23.446663659106754
Free cash flow (dilution-adjusted): 1430000000
Buyback yield (%): 0
Retained earnings: -4383000000
Inventory turnover: 10.920168067226891
Receivables turnover: 77.65286624203821
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.389470395250743
FCF margin (%): 5.864741828323012
Revenue growth (%): 18.461837438662972
Rule of 40 score: 24.326579266985984
Financial ratios for CPNG — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 24.55
Shares outstanding: 1637261211
Market cap (USD): 40194762730.05
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CPNG — annual report dated 2024-12-31
Total revenue: 30268000000
Gross profit: 8831000000
Operating income: 436000000
Net income: 154000000
Capital expenditures: 870000000
Operating cash flow: 1886000000
Depreciation & amortization: 433000000
Net tangible assets: 3832000000
Owner earnings: -283000000
Return on net tangible assets (%): -7.385177453027141
Capex to operating income (%): 199.54128440366972
Buffett classification: The Gruesome
Stock price: 21.98
P/E ratio: 233.6818273881818
Shares outstanding: 1637261211
Book value: 4102000000
P/B ratio: 8.773037888293516
Market cap (USD): 35987001417.78
Debt to equity: 0.9080936128717698
Current ratio: 1.1656298600311041
Quick ratio: 0.8935977190254017
Effective tax rate (%): 86.04651162790698
Interest coverage ratio: 3.1142857142857143
COGS to revenue (%): 70.82397251222413
Free cash flow (dilution-adjusted): 574000000
Buyback yield (%): 0.49462303883995185
Retained earnings: -4229000000
Inventory turnover: 10.212958551691282
Receivables turnover: 74.36855036855037
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.7157839538542214
FCF margin (%): 1.8963922294172062
Revenue growth (%): 24.135668293483164
Rule of 40 score: 26.03206052290037
Financial ratios for CPNG — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 21.98
Shares outstanding: 1637261211
Market cap (USD): 35987001417.78
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CPNG — quarterly report dated 2025-03-31
Total revenue: 7908000000
Gross profit: 2316000000
Operating income: 154000000
Net income: 114000000
Capital expenditures: 238000000
Operating cash flow: 354000000
Depreciation & amortization: 122000000
Net tangible assets: 4157000000
Owner earnings: -2000000
Return on net tangible assets (%): -0.04811161895597787
Capex to operating income (%): 154.54545454545453
Buffett classification: The Gruesome
Stock price: 21.93
P/E ratio: 78.73933850269736
Shares outstanding: 1637261211
Book value: 4398000000
P/B ratio: 8.163969612830831
Market cap (USD): 35905138357.229996
Debt to equity: 0.927694406548431
Current ratio: 1.1636961193275186
Quick ratio: 0.9046896726077613
Effective tax rate (%): 47.22222222222222
Interest coverage ratio: 6.695652173913044
COGS to revenue (%): 70.71320182094082
Free cash flow (dilution-adjusted): -6000000
Buyback yield (%): 0
Retained earnings: -4122000000
Inventory turnover: 2.7291361639824303
Receivables turnover: 16.33884297520661
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.9071207430340558
FCF margin (%): -0.07587253414264036
Rule of 40 score: -0.07587253414264036
Financial ratios for CPNG — quarterly report dated 2025-06-30
Total revenue: 8524000000
Gross profit: 2561000000
Operating income: 149000000
Net income: 32000000
Capital expenditures: 298000000
Operating cash flow: 545000000
Depreciation & amortization: 126000000
Net tangible assets: 4475000000
Owner earnings: -140000000
Return on net tangible assets (%): -3.128491620111732
Capex to operating income (%): 200
Buffett classification: The Gruesome
Stock price: 29.96
P/E ratio: 335.97497179150685
Shares outstanding: 1637261211
Book value: 4685000000
P/B ratio: 10.47008449979936
Market cap (USD): 49052345881.560005
Debt to equity: 0.9773745997865528
Current ratio: 1.0861351264809478
Quick ratio: 0.8422457039171737
Effective tax rate (%): 84.02061855670104
Interest coverage ratio: 5.96
COGS to revenue (%): 69.95541999061473
Free cash flow (dilution-adjusted): 133000000
Buyback yield (%): 0
Retained earnings: -4090000000
Inventory turnover: 2.6096280087527353
Receivables turnover: 17.082164328657313
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.7608130465610965
FCF margin (%): 1.5603003284842798
Revenue growth (%): 7.789580171977745
Rule of 40 score: 9.349880500462024
Financial ratios for CPNG — quarterly report dated 2025-09-30
Total revenue: 9267000000
Gross profit: 2720000000
Operating income: 162000000
Net income: 95000000
Capital expenditures: 350000000
Operating cash flow: 792000000
Depreciation & amortization: 133000000
Net tangible assets: 4540000000
Owner earnings: -122000000
Return on net tangible assets (%): -2.6872246696035242
Capex to operating income (%): 216.04938271604937
Buffett classification: The Gruesome
Stock price: 32.2
P/E ratio: 218.7544024655602
Shares outstanding: 1637261211
Book value: 4741000000
P/B ratio: 11.119977007846446
Market cap (USD): 52719810994.200005
Debt to equity: 1.0438726007171484
Current ratio: 1.0601393112920632
Quick ratio: 0.8161483370940842
Effective tax rate (%): 42.42424242424242
Interest coverage ratio: 7.363636363636363
COGS to revenue (%): 70.64853782238049
Free cash flow (dilution-adjusted): 321000000
Buyback yield (%): 0.15364243246037293
Retained earnings: -3995000000
Inventory turnover: 2.632488942501005
Receivables turnover: 23.580152671755727
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.9115044247787611
FCF margin (%): 3.463904176108773
Revenue growth (%): 8.71656499296105
Rule of 40 score: 12.180469169069823
Financial ratios for CPNG — annual report dated 2025-12-31
Total revenue: 34534000000
Gross profit: 10141000000
Operating income: 473000000
Net income: 214000000
Capital expenditures: 1246000000
Operating cash flow: 1773000000
Depreciation & amortization: 517000000
Net tangible assets: 4433000000
Owner earnings: -515000000
Return on net tangible assets (%): -11.617414843221296
Capex to operating income (%): 263.4249471458774
Buffett classification: The Gruesome
Stock price: 23.59
P/E ratio: 180.4812708761215
Shares outstanding: 1637261211
Book value: 4623000000
P/B ratio: 8.354529951868916
Market cap (USD): 38622991967.49
Debt to equity: 1.0025957170668398
Current ratio: 1.0356952014534573
Quick ratio: 0.7945922838516618
Effective tax rate (%): 64.15410385259631
Interest coverage ratio: 5.5
COGS to revenue (%): 70.63473678114323
Free cash flow (dilution-adjusted): 47000000
Buyback yield (%): 0.6291589222412898
Retained earnings: -4021000000
Inventory turnover: 10.8125
Receivables turnover: 95.13498622589532
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.610913404507711
FCF margin (%): 0.13609775873052643
Revenue growth (%): 14.094092771243558
Rule of 40 score: 14.230190529974085
Financial ratios for CPNG — quarterly report dated 2025-12-31
Total revenue: 8835000000
Gross profit: 2544000000
Operating income: 8000000
Net income: -26000000
Capital expenditures: 360000000
Operating cash flow: 82000000
Depreciation & amortization: 136000000
Net tangible assets: 4433000000
Owner earnings: -250000000
Return on net tangible assets (%): -5.639521768554027
Capex to operating income (%): 4500
Buffett classification: The Gruesome
Stock price: 23.59
P/E ratio: 179.64182310460464
Shares outstanding: 1637261211
Book value: 4623000000
P/B ratio: 8.354529951868916
Market cap (USD): 38622991967.49
Debt to equity: 1.0025957170668398
Current ratio: 1.0356952014534573
Quick ratio: 0.7945922838516618
Effective tax rate (%): 218.18181818181816
Interest coverage ratio: 0.5
COGS to revenue (%): 71.20543293718167
Free cash flow (dilution-adjusted): -401000000
Buyback yield (%): 0.4194392814941932
Retained earnings: -4021000000
Inventory turnover: 2.788563829787234
Receivables turnover: 24.33884297520661
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.09489916963226572
FCF margin (%): -4.538766270514997
Revenue growth (%): -4.661702816445452
Rule of 40 score: -9.20046908696045
Financial ratios for CSCO.TO — quarterly report dated 2025-01-31
Capital expenditures: 0
Depreciation & amortization: 524827586.20689654
Buffett classification: The Gruesome
Stock price: 20.06206896551724
Shares outstanding: 11542953619
Market cap (USD): 231575531570.14484
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CSCO.TO — quarterly report dated 2025-04-30
Total revenue: 10252898550.724638
Gross profit: 6723188405.797102
Operating income: 2344927536.231884
Net income: 1805072463.768116
Capital expenditures: 189130434.78260872
Operating cash flow: 2939855072.4637685
Depreciation & amortization: 453623188.4057971
Net tangible assets: -16472463768.115944
Owner earnings: 2069565217.3913043
Return on net tangible assets (%): -12.563786732359667
Capex to operating income (%): 8.065512978986405
Buffett classification: The Great
Stock price: 20.043478260869566
P/E ratio: 32.04316510453031
Shares outstanding: 11542953619
Book value: 33286231884.057983
P/B ratio: 6.950649768184172
Market cap (USD): 231360939928.6522
Debt to equity: 0.6374006748666592
Current ratio: 0.9513262791708944
Quick ratio: 0.8692274242643862
Effective tax rate (%): 15.473362741771293
Interest coverage ratio: 8.029776674937965
COGS to revenue (%): 34.42646123400947
R&D to revenue (%): 16.502933069474874
SG&A to revenue (%): 24.475227931302566
Free cash flow (dilution-adjusted): 2065942028.9855072
Buyback yield (%): 0.7563938841792701
Retained earnings: 110144927.53623189
Inventory turnover: 1.7199858757062145
Receivables turnover: 1.7181542197935638
Capitalized R&D asset: 1692028985.5072465
ROCI (R&D-adjusted, %): 5.469706999003294
FCF margin (%): 20.14983391052371
Rule of 40 score: 20.14983391052371
Financial ratios for CSCO.TO — quarterly report dated 2025-07-31
Total revenue: 10632608695.652174
Gross profit: 6724637681.159421
Operating income: 2262318840.5797105
Net income: 1847826086.956522
Capital expenditures: 157246376.81159422
Operating cash flow: 3068115942.028986
Depreciation & amortization: 460144927.53623194
Net tangible assets: -15556521739.130436
Owner earnings: 2150724637.68116
Return on net tangible assets (%): -13.825228246692756
Capex to operating income (%): 6.9506726457399095
Buffett classification: The Great
Stock price: 23.681159420289855
P/E ratio: 74.83112959113667
Shares outstanding: 11542953619
Book value: 33944202898.550728
P/B ratio: 8.052936922676173
Market cap (USD): 273350524832.55072
Debt to equity: 0.599726746792477
Current ratio: 0.9977754962354551
Quick ratio: 0.9075404973762262
Effective tax rate (%): 14.971657219073025
Interest coverage ratio: 8.483695652173914
COGS to revenue (%): 36.75458324814285
R&D to revenue (%): 16.220268520411643
SG&A to revenue (%): 24.016901792407825
Free cash flow (dilution-adjusted): 2223913043.478261
Buyback yield (%): 0.4146080692647624
Retained earnings: 36231884.057971016
Inventory turnover: 1.70448798988622
Receivables turnover: 1.5030731407498463
Capitalized R&D asset: 2858297101.449276
ROCI (R&D-adjusted, %): 4.310925551072549
Rosenberg metric: 0.0008565310492506252
FCF margin (%): 20.91596810468207
Revenue growth (%): 3.70344193935967
Rule of 40 score: 24.61941004404174
Financial ratios for CSCO.TO — annual report dated 2025-07-31
Total revenue: 41053623188.4058
Gross profit: 26659420289.855076
Operating income: 9060869565.217392
Net income: 7376811594.202899
Capital expenditures: 655797101.4492754
Operating cash flow: 10284782608.695654
Depreciation & amortization: 2036956521.7391305
Net tangible assets: -15556521739.130436
Owner earnings: 8757971014.492754
Return on net tangible assets (%): -56.2977454816471
Capex to operating income (%): 7.237683941138835
Buffett classification: The Great
Stock price: 23.681159420289855
P/E ratio: 37.05537566492338
Shares outstanding: 11542953619
Book value: 33944202898.550728
P/B ratio: 8.052936922676173
Market cap (USD): 273350524832.55072
Debt to equity: 0.599726746792477
Current ratio: 0.9977754962354551
Quick ratio: 0.9075404973762262
Effective tax rate (%): 8.288288288288289
Interest coverage ratio: 7.84934086629002
COGS to revenue (%): 35.061955025240934
R&D to revenue (%): 16.41543403819677
SG&A to revenue (%): 24.63727186076888
Free cash flow (dilution-adjusted): 6990579710.144928
Buyback yield (%): 1.914513731604932
Retained earnings: 36231884.057971016
Inventory turnover: 6.278128950695322
Receivables turnover: 5.803523868059824
Capitalized R&D asset: 12488491173.58614
ROCI (R&D-adjusted, %): 12.8577754289894
Rosenberg metric: 0.24577226606538916
FCF margin (%): 17.027923888869275
Revenue growth (%): 5.298961024478181
Rule of 40 score: 22.326884913347456
Financial ratios for CSCO.TO — quarterly report dated 2025-10-31
Total revenue: 10630714285.714287
Gross profit: 6960714285.714286
Operating income: 2507142857.142857
Net income: 2042857142.857143
Capital expenditures: 230714285.71428573
Operating cash flow: 2294285714.2857146
Depreciation & amortization: 432857142.85714287
Net tangible assets: -14970714285.714287
Owner earnings: 2245000000
Return on net tangible assets (%): -14.995944462999189
Capex to operating income (%): 9.202279202279204
Buffett classification: The Great
Stock price: 25.092857142857145
P/E ratio: 50.85289850029521
Shares outstanding: 11542953619
Book value: 33480714285.714287
P/B ratio: 8.651120274688413
Market cap (USD): 289645686168.1929
Debt to equity: 0.5992575683229151
Current ratio: 0.9273645313249272
Quick ratio: 0.8315985444698315
Effective tax rate (%): 15.659097611324096
Interest coverage ratio: 10.028571428571427
COGS to revenue (%): 34.522609688906805
R&D to revenue (%): 16.125781092521667
SG&A to revenue (%): 24.215547940603376
Free cash flow (dilution-adjusted): 1310000000
Buyback yield (%): 0.5612768852943517
Retained earnings: -260000000.00000003
Inventory turnover: 1.51340206185567
Receivables turnover: 1.881066734074823
Capitalized R&D asset: 3428162525.8799176
ROCI (R&D-adjusted, %): 3.886720772157018
Rosenberg metric: 0.1368847539015603
FCF margin (%): 12.32278438486864
Revenue growth (%): -0.017816981628053737
Rule of 40 score: 12.304967403240587
Financial ratios for CSCO.TO — quarterly report dated 2026-01-31
Total revenue: 11369629629.62963
Gross profit: 7386666666.666666
Operating income: 2827407407.4074073
Net income: 2351851851.8518515
Capital expenditures: 209629629.6296296
Operating cash flow: 1349629629.6296296
Depreciation & amortization: 488148148.1481481
Net tangible assets: -14679999999.999998
Owner earnings: 2630370370.37037
Return on net tangible assets (%): -17.918054294076093
Capex to operating income (%): 7.414199633219806
Buffett classification: The Great
Stock price: 27.8
P/E ratio: 39.874473102292555
Shares outstanding: 11542953619
Book value: 35350370370.37037
P/B ratio: 9.077531783858309
Market cap (USD): 320894110608.2
Debt to equity: 0.6304297718081429
Current ratio: 0.9550100581743056
Quick ratio: 0.8484477790463764
Effective tax rate (%): 12.918266593527154
Interest coverage ratio: 10.316216216216217
COGS to revenue (%): 35.031598149716594
R&D to revenue (%): 15.343019089191479
SG&A to revenue (%): 23.252329141963642
Free cash flow (dilution-adjusted): 448148148.1481482
Buyback yield (%): 0.24907258588959444
Retained earnings: 48888888.88888889
Inventory turnover: 1.3716836734693878
Receivables turnover: 1.6072251308900523
Capitalized R&D asset: 3462146307.798482
ROCI (R&D-adjusted, %): 4.20724398012412
Rosenberg metric: 0.24847222222222176
FCF margin (%): 3.941624861554499
Revenue growth (%): 6.9507591310991
Rule of 40 score: 10.892383992653599
Financial ratios for CYB.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.8721804511278193
Shares outstanding: 208747622
Market cap (USD): 599560839.1278195
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CYB.AX — annual report dated 2022-06-30
Total revenue: 2925708.275862069
Gross profit: 2925708.275862069
Operating income: -10813066.206896553
Net income: -10704585.51724138
Capital expenditures: 3059633.103448276
Depreciation & amortization: 2912348.9655172415
Net tangible assets: 25887424.827586208
Owner earnings: -10851869.655172413
Return on net tangible assets (%): -41.919463706596346
Buffett classification: The Gruesome
Stock price: 1.0482758620689656
Shares outstanding: 208747622
Book value: 26117285.51724138
P/B ratio: 8.37855424379531
Market cap (USD): 218825093.40689656
Debt to equity: 0.11860716686404332
Current ratio: 5.4103014979999084
Quick ratio: 5.4103014979999084
COGS to revenue (%): 0
SG&A to revenue (%): 224.72716892367
Free cash flow (dilution-adjusted): -10754193.793103449
Buyback yield (%): 0.3112106047570234
Retained earnings: -34774091.03448276
Receivables turnover: 7.711408212604293
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -38.93274497233479
FCF margin (%): -367.5757382179429
Rule of 40 score: -367.5757382179429
Financial ratios for CYB.AX — annual report dated 2023-06-30
Total revenue: 4289773.509933774
Gross profit: 4289773.509933774
Operating income: -14152062.251655629
Net income: -14094977.48344371
Capital expenditures: 3099154.304635762
Depreciation & amortization: 3567072.1854304634
Net tangible assets: 16255729.139072848
Owner earnings: -13627059.602649007
Return on net tangible assets (%): -83.8292732738424
Buffett classification: The Gruesome
Stock price: 0.2913907284768212
Shares outstanding: 208747622
Book value: 16492614.569536423
P/B ratio: 3.688143040384763
Market cap (USD): 60827121.642384104
Debt to equity: 0.21080469170868696
Current ratio: 3.275953006182997
Quick ratio: 3.275953006182997
COGS to revenue (%): 0
SG&A to revenue (%): 205.24038534274803
Free cash flow (dilution-adjusted): -14907541.059602648
Buyback yield (%): 0.08486650841072488
Retained earnings: -47487316.556291394
Receivables turnover: 6.080792378120045
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -74.51107543286068
FCF margin (%): -347.51347652927234
Revenue growth (%): 46.623419201621516
Rule of 40 score: -300.8900573276508
Financial ratios for CYB.AX — annual report dated 2024-06-30
Total revenue: 6820081.333333333
Gross profit: 6820081.333333333
Operating income: -13433244
Net income: -13145400
Capital expenditures: 72050.66666666667
Depreciation & amortization: 4273530.666666667
Net tangible assets: 9248478
Owner earnings: -8943919.999999998
Return on net tangible assets (%): -96.70693923908343
Buffett classification: The Gruesome
Stock price: 0.19333333333333333
Shares outstanding: 208747622
Book value: 28495973.33333333
P/B ratio: 1.41626583919693
Market cap (USD): 40357873.586666666
Debt to equity: 0.11917704864032254
Current ratio: 1.6075544117315987
Quick ratio: 1.6075544117315987
COGS to revenue (%): 0
SG&A to revenue (%): 140.47290931623297
Free cash flow (dilution-adjusted): -7752872.666666667
Buyback yield (%): 2.894437267178661
Retained earnings: -60949299.333333336
Receivables turnover: 2.3465089501160623
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -43.2718689749159
FCF margin (%): -113.67712916815655
Revenue growth (%): 58.984648432840494
Rule of 40 score: -54.69248073531606
Financial ratios for DAIC — quarterly report dated 2025-06-30
Total revenue: 126833
Gross profit: 59639
Operating income: -1721554
Net income: -28859203
Capital expenditures: 465385
Operating cash flow: -2041273
Depreciation & amortization: 36742
Net tangible assets: -658743
Owner earnings: -29287846
Buffett classification: The Gruesome
Stock price: 128.25
Shares outstanding: 1210383
Book value: 1739251
P/B ratio: 89.2519939617686
Market cap (USD): 155231619.75
Debt to equity: 0.4495090127876885
Current ratio: 1.0649523057467714
Quick ratio: 1.0131046183601418
Interest coverage ratio: -10.201015625462928
COGS to revenue (%): 52.97832583002846
R&D to revenue (%): 143.21272854856386
SG&A to revenue (%): 1257.1262999377134
Free cash flow (dilution-adjusted): -2516395
Buyback yield (%): 0
Retained earnings: -54877024
Inventory turnover: 0.18539651357212625
Receivables turnover: 7.959397552557264
Capitalized R&D asset: 445529.88
ROCI (R&D-adjusted, %): -41.14638457593127
Rosenberg metric: -0.7001934677959905
FCF margin (%): -1984.0222970362604
Revenue growth (%): -64.0188029435628
Rule of 40 score: -2048.0410999798232
Financial ratios for DAIC — quarterly report dated 2025-09-30
Total revenue: 778482
Gross profit: 290196
Operating income: -3973325
Net income: -4216555
Capital expenditures: 376524
Operating cash flow: -4435088
Depreciation & amortization: 11738
Net tangible assets: -4778378
Owner earnings: -4581341
Buffett classification: The Gruesome
Stock price: 63.5
Shares outstanding: 1210383
Book value: -2118184
Market cap (USD): 76859320.5
Debt to equity: -0.35412504296132913
Current ratio: 0.39621139903134733
Quick ratio: 0.34391045795361963
COGS to revenue (%): 66.78728602588114
R&D to revenue (%): 51.01402473018002
SG&A to revenue (%): 495.1492776968511
Free cash flow (dilution-adjusted): -5082932
Buyback yield (%): 0
Retained earnings: -59093579
Inventory turnover: 1.110713049719933
Receivables turnover: 0.8507748951670279
Capitalized R&D asset: 648809.59
Rosenberg metric: 1.2693004332722237
FCF margin (%): -652.9286483181371
Revenue growth (%): 513.7850559397003
Rule of 40 score: -139.14359237843678
Financial ratios for DAIC — quarterly report dated 2025-12-31
Total revenue: 4546556
Gross profit: 1985975
Operating income: -2193951
Net income: -2357755
Capital expenditures: 186693
Operating cash flow: -5052703
Depreciation & amortization: 19624
Net tangible assets: -2681252
Owner earnings: -2524824
Buffett classification: The Gruesome
Stock price: 11.23
Shares outstanding: 1210383
Book value: 239466
P/B ratio: 56.76213362230964
Market cap (USD): 13592601.09
Debt to equity: 9.430441064702295
Current ratio: 0.7872498324530715
Quick ratio: 0.6112940771392208
Interest coverage ratio: -28.920670700359867
COGS to revenue (%): 56.31913474726804
R&D to revenue (%): 10.415862028313299
SG&A to revenue (%): 81.08860860836202
Free cash flow (dilution-adjusted): -5508885
Buyback yield (%): 0
Retained earnings: -61451334
Inventory turnover: 1.7895135933735928
Receivables turnover: 1.2543790989605046
Capitalized R&D asset: 799584.98
ROCI (R&D-adjusted, %): -61.54629695648117
Rosenberg metric: 4.270031601344631
FCF margin (%): -121.16610902846023
Revenue growth (%): 484.02840399649574
Rule of 40 score: 362.8622949680355
Financial ratios for DAIC — annual report dated 2025-12-31
Total revenue: 5804369
Gross profit: 2671230
Operating income: -9247754
Net income: -36718071
Capital expenditures: 670417
Operating cash flow: -13250533
Depreciation & amortization: 36463
Net tangible assets: -2681252
Owner earnings: -37352025
Buffett classification: The Gruesome
Stock price: 11.23
Shares outstanding: 1210383
Book value: 239466
P/B ratio: 56.76213362230964
Market cap (USD): 13592601.09
Debt to equity: 9.430441064702295
Current ratio: 0.7872498324530715
Quick ratio: 0.6112940771392208
Interest coverage ratio: -22.85517912926569
COGS to revenue (%): 53.9789768706986
R&D to revenue (%): 24.915766037617527
SG&A to revenue (%): 179.80107742977748
Free cash flow (dilution-adjusted): -15118099
Buyback yield (%): 36.78471814845263
Retained earnings: -61451334
Inventory turnover: 2.1896572810736883
Receivables turnover: 1.6014053618286643
Capitalized R&D asset: 2292237.3600000003
ROCI (R&D-adjusted, %): -182.10012872798674
Rosenberg metric: 2.9899089808893975
FCF margin (%): -260.4606805666559
Revenue growth (%): 3261.7139944747223
Rule of 40 score: 3001.2533139080665
Financial ratios for DLCG.TO — annual report dated 2021-12-31
Capital expenditures: 22047.24409448819
Buffett classification: The Gruesome
Stock price: 2.5984251968503935
Shares outstanding: 77035591
Market cap (USD): 200171220.7086614
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DLCG.TO — annual report dated 2022-12-31
Total revenue: 51999999.99999999
Gross profit: 44129411.76470588
Operating income: 19401470.588235293
Net income: 9033823.529411765
Capital expenditures: 9558.823529411764
Operating cash flow: 11671323.529411763
Depreciation & amortization: 5330882.352941176
Net tangible assets: -113077205.88235293
Owner earnings: 14355147.05882353
Return on net tangible assets (%): -12.694996261013754
Capex to operating income (%): 0.04926855150458576
Buffett classification: The Great
Stock price: 2.125
P/E ratio: 18.120857723425036
Shares outstanding: 77035591
Book value: 23668382.352941155
P/B ratio: 6.9164266671844485
Market cap (USD): 163700630.875
Debt to equity: 1.2093572338376475
Current ratio: 0.6914525241479861
Quick ratio: 0.6914525241479861
Effective tax rate (%): 35.313010056336545
Interest coverage ratio: 5.738581992170508
COGS to revenue (%): 15.135746606334841
SG&A to revenue (%): 41.91883484162896
Free cash flow (dilution-adjusted): 6424264.705882353
Buyback yield (%): 3.3013994728173235
Retained earnings: -85763235.29411764
Receivables turnover: 4.989769279616171
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.222112026217065
FCF margin (%): 12.354355203619912
Rule of 40 score: 12.354355203619912
Financial ratios for DLCG.TO — annual report dated 2023-12-31
Total revenue: 47361363.63636363
Gross profit: 39460606.06060606
Operating income: 13871969.696969695
Net income: 48484.84848484848
Capital expenditures: 52272.72727272727
Operating cash flow: 12870454.545454545
Depreciation & amortization: 6556818.181818182
Net tangible assets: -122463636.36363636
Owner earnings: 6553030.303030303
Return on net tangible assets (%): -5.351000915546978
Capex to operating income (%): 0.376822674894872
Buffett classification: The Great
Stock price: 2.015151515151515
P/E ratio: 3201.7917509375
Shares outstanding: 77035591
Book value: 19658333.333333343
P/B ratio: 7.896823463717287
Market cap (USD): 155238387.92424244
Debt to equity: 1.605572469073952
Current ratio: 0.6805488685604236
Quick ratio: 0.6805488685604236
Effective tax rate (%): 98.47145927871985
Interest coverage ratio: 6.1425696075142575
COGS to revenue (%): 16.681862533390916
SG&A to revenue (%): 47.970951901082906
Free cash flow (dilution-adjusted): 3981060.606060606
Buyback yield (%): 0.15079447308171437
Retained earnings: -92718181.81818181
Receivables turnover: 4.168077871858124
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.904530087897227
FCF margin (%): 8.40571364588832
Revenue growth (%): -8.920454545454538
Rule of 40 score: -0.5147408995662186
Financial ratios for DLCG.TO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.9777777777777774
Shares outstanding: 77035591
Market cap (USD): 229394870.97777775
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DLCG.TO — annual report dated 2024-12-31
Total revenue: 53673426.573426574
Gross profit: 46106293.70629371
Operating income: 20640559.440559443
Net income: -88648951.04895106
Capital expenditures: 4755944.055944056
Operating cash flow: 26015384.615384616
Depreciation & amortization: 6390909.090909091
Net tangible assets: -40761538.461538464
Owner earnings: -87013986.01398602
Capex to operating income (%): 23.041740073180648
Buffett classification: The Great
Stock price: 5.3426573426573425
Shares outstanding: 77035591
Book value: 93500000
P/B ratio: 4.4018691540331325
Market cap (USD): 411574765.9020979
Debt to equity: 0.27927900976029324
Current ratio: 0.592854165134015
Quick ratio: 0.592854165134015
Interest coverage ratio: 11.978896103896105
COGS to revenue (%): 14.098471720975075
SG&A to revenue (%): 42.156006931325166
Free cash flow (dilution-adjusted): 20872027.972027972
Buyback yield (%): 2.763052770522151
Retained earnings: -178524475.52447554
Receivables turnover: 4.468358851953193
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.57168844147751
FCF margin (%): 38.88707933240394
Revenue growth (%): 13.327451856172054
Rule of 40 score: 52.214531188576
Financial ratios for DLCG.TO — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.3426573426573425
Shares outstanding: 77035591
Market cap (USD): 411574765.9020979
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DLCG.TO — quarterly report dated 2025-03-31
Total revenue: 13099300.6993007
Gross profit: 11610489.51048951
Operating income: 4814685.314685315
Net income: 4382517.482517483
Capital expenditures: 849650.3496503497
Operating cash flow: 5414685.314685315
Depreciation & amortization: 1612587.4125874126
Net tangible assets: -37439860.13986014
Owner earnings: 5145454.545454546
Return on net tangible assets (%): -13.743252582229779
Capex to operating income (%): 17.647058823529413
Buffett classification: The Great
Stock price: 5.230769230769232
P/E ratio: 22.986525477900113
Shares outstanding: 77035591
Book value: 95946853.14685315
P/B ratio: 4.199777125156702
Market cap (USD): 402955399.07692313
Debt to equity: 0.23098451940176673
Current ratio: 0.5976492421899164
Quick ratio: 0.5976492421899164
Effective tax rate (%): 20.811220621683095
Interest coverage ratio: 16.011627906976745
COGS to revenue (%): 11.365577621183002
SG&A to revenue (%): 46.2844330557335
Free cash flow (dilution-adjusted): 4504195.8041958045
Buyback yield (%): 0.08555667588646253
Retained earnings: -175816783.21678323
Receivables turnover: 1.6301453311287095
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.822494142728656
FCF margin (%): 34.38500960922485
Rule of 40 score: 34.38500960922485
Financial ratios for DLCG.TO — quarterly report dated 2025-06-30
Total revenue: 17962773.722627737
Gross profit: 15615328.467153283
Operating income: 8057664.233576641
Net income: 5639416.05839416
Capital expenditures: 27737.22627737226
Operating cash flow: 7866423.357664233
Depreciation & amortization: 1697080.2919708027
Net tangible assets: -36043795.62043795
Owner earnings: 7308759.124087591
Return on net tangible assets (%): -20.27744025921426
Capex to operating income (%): 0.34423407917383825
Buffett classification: The Great
Stock price: 6.37956204379562
P/E ratio: 49.037776029819746
Shares outstanding: 77035591
Book value: 102468613.13868612
P/B ratio: 4.79613529754527
Market cap (USD): 491453332.36496353
Debt to equity: 0.21455029847131402
Current ratio: 0.6575285737949312
Quick ratio: 0.6575285737949312
Effective tax rate (%): 26.46106986483914
Interest coverage ratio: 29.281167108753316
COGS to revenue (%): 13.068389613556016
SG&A to revenue (%): 37.82356048600105
Free cash flow (dilution-adjusted): 6394890.510948904
Buyback yield (%): 0.2769975863348503
Retained earnings: -180227737.22627735
Receivables turnover: 1.4584839684703372
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.055004607486068
FCF margin (%): 35.600796456580916
Revenue growth (%): 37.12773021224461
Rule of 40 score: 72.72852666882552
Financial ratios for DLCG.TO — quarterly report dated 2025-09-30
Total revenue: 18979136.690647483
Gross profit: 17180575.539568346
Operating income: 9125179.856115108
Net income: 6443165.4676259
Capital expenditures: 719.4244604316548
Operating cash flow: 6721582.733812951
Depreciation & amortization: 1701438.8489208634
Net tangible assets: -38030935.25179856
Owner earnings: 8143884.892086332
Return on net tangible assets (%): -21.413843330874148
Capex to operating income (%): 0.007883948281299276
Buffett classification: The Great
Stock price: 7.633093525179857
P/E ratio: 35.71310871350372
Shares outstanding: 77035591
Book value: 99297841.7266187
P/B ratio: 5.921778969671941
Market cap (USD): 588019870.8705037
Debt to equity: 0.25825943314206223
Current ratio: 0.6310982036208633
Quick ratio: 0.6310982036208633
Effective tax rate (%): 26.523915005332682
Interest coverage ratio: 33.73404255319149
COGS to revenue (%): 9.476517190402184
SG&A to revenue (%): 38.489822220537505
Free cash flow (dilution-adjusted): 3943884.892086331
Buyback yield (%): 1.0624610364169713
Retained earnings: -173520863.30935252
Receivables turnover: 1.2905924367692383
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.067043308205324
FCF margin (%): 20.780106895113907
Revenue growth (%): 5.658162729842953
Rule of 40 score: 26.43826962495686
Financial ratios for DLCG.TO — annual report dated 2025-12-31
Total revenue: 70272992.70072992
Gross profit: 62167153.28467153
Operating income: 31630656.934306566
Net income: 18129197.080291968
Capital expenditures: 4832846.715328467
Operating cash flow: 23363503.649635036
Depreciation & amortization: 6877372.262773722
Net tangible assets: -38594890.510948904
Owner earnings: 20173722.627737224
Return on net tangible assets (%): -52.270449172576825
Capex to operating income (%): 15.278995707758344
Buffett classification: The Great
Stock price: 7.226277372262773
P/E ratio: 30.706299106172246
Shares outstanding: 77035591
Book value: 98772262.77372262
P/B ratio: 5.636000760430985
Market cap (USD): 556680548.1021898
Debt to equity: 0.2676066746478665
Current ratio: 0.5761196007419839
Quick ratio: 0.5761196007419839
Effective tax rate (%): 27.050841483831174
Interest coverage ratio: 28.8125
COGS to revenue (%): 11.534786131250389
SG&A to revenue (%): 39.11336394042005
Free cash flow (dilution-adjusted): 17267883.211678833
Buyback yield (%): 1.5097311358723826
Retained earnings: -177389051.0948905
Receivables turnover: 4.533741464563222
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 24.983280677074927
FCF margin (%): 24.57257411139041
Revenue growth (%): 30.926972967888922
Rule of 40 score: 55.49954707927933
Financial ratios for DLCG.TO — quarterly report dated 2025-12-31
Total revenue: 19381021.897810217
Gross profit: 17001459.854014598
Operating income: 9289051.09489051
Net income: 1378102.1897810218
Capital expenditures: 496350.3649635036
Operating cash flow: 3025547.445255474
Depreciation & amortization: 1770802.9197080291
Net tangible assets: -38594890.510948904
Owner earnings: 2652554.744525547
Return on net tangible assets (%): -6.872813238770685
Capex to operating income (%): 5.343391482005344
Buffett classification: The Great
Stock price: 7.226277372262773
P/E ratio: 31.198468364221995
Shares outstanding: 77035591
Book value: 98772262.77372262
P/B ratio: 5.636000760430985
Market cap (USD): 556680548.1021898
Debt to equity: 0.2676066746478665
Current ratio: 0.5761196007419839
Quick ratio: 0.5761196007419839
Effective tax rate (%): 45.084351367073886
Interest coverage ratio: 39.64485981308412
COGS to revenue (%): 12.277794516420608
SG&A to revenue (%): 35.86923772220548
Free cash flow (dilution-adjusted): 2170072.99270073
Buyback yield (%): 0.06188927359143344
Retained earnings: -177389051.0948905
Receivables turnover: 1.2503885095361431
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.336900122224016
FCF margin (%): 11.196896655619163
Revenue growth (%): 2.1175104732807717
Rule of 40 score: 13.314407128899935
Financial ratios for DOCS.L — annual report dated 2022-03-31
Total revenue: 1195131578.9473684
Gross profit: 761578947.3684211
Operating income: 296447368.42105263
Net income: 238421052.63157895
Capital expenditures: 20394736.842105262
Operating cash flow: 242631578.9473684
Depreciation & amortization: 48552631.578947365
Net tangible assets: 86973684.21052632
Owner earnings: 266578947.36842108
Return on net tangible assets (%): 306.5052950075643
Capex to operating income (%): 6.879715934309809
Buffett classification: The Great
Stock price: 0.027499999999999997
P/E ratio: 0.1103954540066225
Shares outstanding: 957112740
Book value: 431842105.26315784
P/B ratio: 0.06094959252285192
Market cap (USD): 26320600.349999998
Debt to equity: 1.1998781230956734
Current ratio: 2.8619354838709676
Quick ratio: 2.0683870967741935
Effective tax rate (%): 15.445636957536166
Interest coverage ratio: 16.20863309352518
COGS to revenue (%): 36.276560607728726
Free cash flow (dilution-adjusted): 202894736.84210524
Buyback yield (%): 0
Retained earnings: 2251710526.315789
Inventory turnover: 2.678861788617886
Receivables turnover: 11.967061923583664
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 31.998295696634006
FCF margin (%): 16.976769789717054
Rule of 40 score: 16.976769789717054